{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:20:02Z","timestamp":1758637202211},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[1992,9]]},"DOI":"10.1038\/eye.1992.111","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T10:59:32Z","timestamp":1309777172000},"page":"525-529","source":"Crossref","is-referenced-by-count":2,"title":["Sezolamide: Additivity to timolol twice daily"],"prefix":"10.1038","volume":"6","author":[{"given":"Frans","family":"Gunning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"B\u00e9chetoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik A","family":"Lippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen","family":"Gerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Holder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coleen","family":"Clineschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Buntinx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise L","family":"Brunner-Ferber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Grehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFeye1992111_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/archopht.1989.01070020209026","volume":"107","author":"AM Bron","year":"1989","unstructured":"Bron AM, Lippa EA, Hofmann HM, Feicht B, Royer J, Brunner-Ferber F, et al.: MK-927: a topically effective carbonic anhydrase inhibitor in patients. Arch Ophthalmol 1989, 107: 1143\u20136.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bjo.74.7.405","volume":"74","author":"N Pfeiffer","year":"1990","unstructured":"Pfeiffer N, Hennekes R, Lippa EA, Grehn F, Garus H, Brunner-Ferber FL : Single-dose efficacy of a novel topical carbonic anhydrase inhibitor. Br J Ophthalmol 1990, 74: 405.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1992111_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archopht.1990.01070030071031","volume":"108","author":"EJ Higginbotham","year":"1990","unstructured":"Higginbotham EJ, Kass MA, Lippa EA, Batenhorst RL, Panebianco DL, Wilensky JT : MK-927, a topical carbonic anhydrase inhibitor; dose response and duration of action. Arch Ophthalmol 1990, 108: 65.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/archopht.1990.01070080080039","volume":"108","author":"JB Serle","year":"1990","unstructured":"Serle JB, Lustgarten JS, Lippa EA, Camras CB, Panebianco DL, Podos SM : MK-927, a topical carbonic anhydrase inhibitor: dose response and reproducibility. Arch Ophthalmol 1990, 108: 838.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/archopht.1991.01080010048030","volume":"109","author":"EA Lippa","year":"1991","unstructured":"Lippa EA, Aasved H, Airaksinen PJ, AIm A, Bertelsen T, Calissendorff B, et al.: Multiple-dose dose-response relationship for the topical carbonic anhydrase inhibitor MK-927. Arch Ophthalmol 1991, 109: 46.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR6","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1021\/jm00132a003","volume":"32","author":"J Baldwin","year":"1989","unstructured":"Baldwin J, Ponticello G, Anderson P, Christy M, Murcko M, Randall W, et al.: Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J Med Chem 1989, 32: 2510.","journal-title":"J Med Chem"},{"key":"BFeye1992111_CR7","first-page":"131","volume":"87","author":"M Diestelhorst","year":"1990","unstructured":"Diestelhorst M, B\u00e9chetoille A, Lippa EA, Brunner-Ferber FL, Krieglstein GK : Zur Stereospezifit\u00e4t der Augendrucksenkung eines lokal applizierten Karboanhydrasehemmers. Fortschr Ophthalmol 1990, 87: 131.","journal-title":"Fortschr Ophthalmol"},{"key":"BFeye1992111_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/archopht.1991.01080010052031","volume":"109","author":"A Bron","year":"1991","unstructured":"Bron A, Lippa EA, Gunning F, B\u00e9nichou MD, Lesure P, Sirbat D, et al.: Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors MK-417 and MK-927. Arch Ophthalmol 1991, 109: 50.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR9","first-page":"232","volume":"31 (suppl)","author":"EA Lippa","year":"1990","unstructured":"Lippa EA, Sherwood M, Laibovitz RM, Miller E, McMahon C, Clineschmidt C, Caprioli J : MK-417 vs. timolol : comparative activity. Invest Ophthalmol Vis Sci 1990, 31 (suppl): 232.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1992111_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0002-9394(54)92027-9","volume":"37","author":"B Becker","year":"1954","unstructured":"Becker B : Decrease in intraocular pressure by a carbonic anhydrase inhibitor, Diamox. Am J Ophthamol 1954, 37: 13.","journal-title":"Am J Ophthamol"},{"key":"BFeye1992111_CR11","first-page":"498","volume":"15","author":"IM Katz","year":"1976","unstructured":"Katz IM, Hubbard WA, Getson AJ, Gould AL : Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol Vis Sci 1976, 15: 498.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1992111_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0161-6420(78)35673-6","volume":"85","author":"WP Boger","year":"1978","unstructured":"Boger WP, III, Puliafito CA, Steinert RF, Langston DP : Long-term experience with timolol ophthalmic solution in patients with open angle glaucoma. Ophthalmology 1978, 85: 259.","journal-title":"Ophthalmology"},{"key":"BFeye1992111_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1755-3768.1978.tb01363.x","volume":"56","author":"NV Nielsen","year":"1978","unstructured":"Nielsen NV : Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure. Acta Ophthalmol 1978, 56: 504\u20139.","journal-title":"Acta Ophthalmol"},{"key":"BFeye1992111_CR14","first-page":"202","volume":"173","author":"P Bischoff","year":"1978","unstructured":"Bischoff P : Erfahrungen mit timolol in der glaukom therapie. Klin Monatsbl Augenheilkd 1978, 173: 202.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BFeye1992111_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00409999","volume":"210","author":"W Leydhecker","year":"1979","unstructured":"Leydhecker W, Krieglstein GK : The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979, 210: 135.","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"BFeye1992111_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/bjo.61.5.345","volume":"61","author":"MJ MacDonald","year":"1977","unstructured":"MacDonald MJ, Gore SM, Cullen PM, Phillips CI : Comparison of ocular hypotensive effects of acetazolamide and atenolol. Br J Ophthalmol 1977, 61: 345.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1992111_CR17","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1001\/archopht.1984.01040031458022","volume":"102","author":"JP Smith","year":"1984","unstructured":"Smith JP, Weeks RH, Newland EF, Ward RL : Betaxolol and acetazolamide. Combined ocular hypotensive effect. Arch Ophthalmol 1984, 102: 1794.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0002-9394(79)90516-6","volume":"88","author":"EU Keates","year":"1979","unstructured":"Keates EU : Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Am J Ophthalmol 1979, 88: 565.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1992111_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0002-9394(82)90419-6","volume":"93","author":"RA Dailey","year":"1982","unstructured":"Dailey RA, Brubaker RF, Bourne WM : The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol 1982, 93: 232.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1992111_CR20","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1001\/archopht.1978.03910060433007","volume":"96","author":"RL Coakes","year":"1978","unstructured":"Coakes RL, Brubaker RF : The mechanism of timolol in lowering intraocular pressure in the normal eye. Arch Ophthalmol 1978, 96: 2045.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0014-4835(78)90083-0","volume":"27","author":"ME Yablonski","year":"1978","unstructured":"Yablonski ME, Zimmerman TJ, Waltman SR, Becker B : A fluorophotometric study of the effect of topical timolol on aqueous humour dynamics. Exp Eye Res 1978, 27: 135.","journal-title":"Exp Eye Res"},{"key":"BFeye1992111_CR22","first-page":"623","volume":"16","author":"TJ Zimmerman","year":"1977","unstructured":"Zimmerman TJ, Harbin R, Pett M, Kaufman HE : Timolol and facility of outflow. Invest Ophthalmol Vis Sci 1977, 16: 623.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1992111_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0002-9394(14)75631-4","volume":"92","author":"FG Berson","year":"1981","unstructured":"Berson FG, Epstein DL : Separate and combined effect of timolol maleate and acetazolamide in open-angle glaucoma. Am J Ophthalmol 1981, 92: 788.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1992111_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/archopht.1982.01030030949010","volume":"100","author":"MA Kass","year":"1982","unstructured":"Kass MA, Korey M, Gordon M, Becker B : Timolol and acetazolamide. A study of concurrent administration. Arch Ophthalmol 1982, 100: 941.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1992111_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00587604","volume":"212","author":"A Scharrer","year":"1979","unstructured":"Scharrer A, Ober M : Timolol and acetazolamide in the treatment of increased intraocular pressure (author's translation). Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979, 212: 129.","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"BFeye1992111_CR26","unstructured":"Hoskins HD, Kass MA, editors. Adrenergic antagonists. In: Becker-Shaffers's diagnosis and therapy of the glaucomas, 6th ed. St. Louis, Mosby, 1989, p. 454."},{"key":"BFeye1992111_CR27","first-page":"356","volume":"15","author":"TH Maren","year":"1976","unstructured":"Maren TH : The rates of movement of NA+, Cl\u2212, and HCO\u22123 from plasma to posterior chamber: effect of acetazolamide and relation to the treatment of glaucoma. Invest Ophthalmol 1976, 15: 356.","journal-title":"Invest Ophthalmol"},{"key":"BFeye1992111_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ddr.430100407","volume":"10","author":"TH Maren","year":"1987","unstructured":"Maren TH : Carbonic anhydrase: general perspectives and advances in glaucoma research. Drug Dev Res 1987, 10: 255.","journal-title":"Drug Dev Res"},{"key":"BFeye1992111_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1755-3768.1980.tb08304.x","volume":"58","author":"B Calissendorff","year":"1980","unstructured":"Calissendorff B, Maren N, Wettrell K, Ostberg A : Timolol versus pilocarpine separately or combined with acetazolamide effects on intraocular pressure. Acta Ophthalmol 1980, 58: 624.","journal-title":"Acta Ophthalmol"},{"key":"BFeye1992111_CR30","unstructured":"Buclin T., Biollaz J, Lippa EA, Brunner-Ferber F, Van Melle G, Munafo A, et al.: Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during prolonged ocular administration to normal subjects. J Clin Pharmacol Ther In press."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye1992111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye1992111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye1992111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:28:00Z","timestamp":1684430880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye1992111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,9]]}},"alternative-id":["BFeye1992111"],"URL":"https:\/\/doi.org\/10.1038\/eye.1992.111","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}